• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Ado-Trastuzumab Emtansine

Pharmacogenomic Information
  

Drug Link
in Drugs@FDA
Therapeutic AreaHUGO SymbolReferenced
Subgroup
Label Sections with
Pharmacogenomic
Information
Ado-Trastuzumab EmtansineOncologyERBB2HER2 protein overexpression or
gene amplification positive
Indications and Usage
Warnings and Precautions
Adverse Reactions
Clinical Pharmacology
Clinical Studies 

 

back to Table of Pharmacogenomic Biomarkers in Drug Labeling